Royal Harbor Partners’s Bristol-Myers Squibb BMY Stock Holding History

Royal Harbor Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-19,636	Closed	-$1.16M	–	79
2021 Q3	$1.16M	Buy	19,636 +172	+0.9%	+$11.3K	0.83%	47
2021 Q2	$1.3M	Buy	19,464 +581	+3%	+$37.9K	0.87%	42
2021 Q1	$1.19M	Buy	18,883 +1,072	+6%	+$66.7K	0.91%	34
2020 Q4	$1.1M	Buy	17,811 +3,751	+27%	+$231K	0.92%	39
2020 Q3	$848K	Buy	14,060 +57	+0.4%	+$3.43K	0.79%	34
2020 Q2	$823K	Sell	14,003 -6,197	-31%	-$371K	0.81%	32
2020 Q1	$1.13M	Buy	+20,200	New	+$1.23M	1.3%	21

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Harbor Partners's BMY Position: Q4 2021 in Review

Royal Harbor Partners sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 19,636 shares — an estimated $1.16M sold.

Royal Harbor Partners first reported a position in BMY in Q1 2020 and held it in 7 quarters. The position peaked at $1.3M in Q2 2021. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Royal Harbor Partners reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
Royal Harbor Partners sold 19,636 Bristol-Myers Squibb shares in Q4 2021, an estimated $1.16M.
Royal Harbor Partners first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 7 quarters.
Royal Harbor Partners's Bristol-Myers Squibb position peaked at $1.3M in Q2 2021.
2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Royal Harbor Partners's 13F filing for Q4 2021, filed 2 Feb 2022.